Registration is open for the 2024 ASRM Scientific Congress & Expo
This document provides the latest recommendations for the evaluation of potential sperm, oocyte, and embryo donors, as well as their recipients, incorporating recent information about optimal
Donor sperm use has increased in the United States in the last 2 decades, accounting for 6% of in vitro fertilization (IVF) treatment cycles in 2014 (1). Donor sperm banks, through their
To evaluate the effect of relugolix combination therapy (relugolix CT; 40 mg relugolix, 1 mg estradiol, and 0.5 mg norethisterone acetate) for up to 2 years in the SPIRIT long-term extension study
To evaluate the technical accuracy, inheritance, and pathogenicity of small copy number variants (CNVs) detected by a targeted next-generation sequencing (NGS)-based PGT-A platform.
To report utilization, effectiveness, and safety of assisted reproductive technologies in 2015 and 2016.
To characterize the literature on social oocyte preservation, specifically the return rates, thaw rates, clinical pregnancy rates, and live birth rates.
The objective of this narrative review is to advocate for improved comprehensive care of patients with obesity and infertility. Persons with an increased body mass index have less successful
We read with interest the publication of Diaz-Gimeno et al. (1), which looked at endometrial markers of possible decreased receptivity in assisted reproductive technology (ART) therapy in women
The use of cryopreserved donor oocytes in the United States has been steadily increasing (1–3). One question that remains unanswered about cryopreserved donor oocytes is whether there is a
Displaying 1 to 10 of 1618 records